Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The Aicardi syndrome market has undergone changes in recent years. Aicardi syndrome is defined by the absence of a structure called the corpus callosum, which connects the two hemispheres of the brain, along with some other neurological features. One prominent trend is an emphasis on advancing genetic diagnostics. The development of novel advanced genomic sequencing technologies has allowed for more accurate and timely diagnosis of Aicardi’s syndrome and enabled doctors to confirm that certain genetic mutations associated with the condition are present or not. This tendency helps in early detection as well as enlightening families about what they should expect from Aicardi syndrome.
In most cases, treatment modalities for Aicardi Syndrome have been only symptomatic and supportive, based upon individual patient needs. Nonetheless, a multidisciplinary approach that sees healthcare practitioners collaborate in every aspect of care provided to patients is gradually becoming popular. This means different practitioners work together such as neurologists, developmental specialists, therapists among others to develop specific individualized comprehensive treatment plans for these patients with various symptoms and challenges caused by Aicardi Syndrome hence improving their living standard.
Another major trend in the market are advancements being made in neurorehabilitation therapies for those people who may suffer from this disease referred to as Aicardi syndrome. In fact, intervention techniques like physical therapy, occupational therapy and speech therapy now focus more on addressing the particular neurodevelopmental requirements unique to persons affected by this illness – all geared toward improving movement skills, verbal communication capabilities plus self-reliance attributes necessary for better quality life.
Moreover, patient advocacy groups and non-profit organizations have become increasingly involved in the field of this disorder known as Aicardi syndrome. Some roles played by these factions include creating awareness on such rare diseases amongst societies; supporting victims’ families through provision of relevant information/guidelines; initiating research findings showing that medical professionals themselves understand how serious “topic” is; discovering new ways of managing these diseases as well as fostered supportive networks within the confines of these disorders.
Moreover, various digital health solutions and telemedicine are heavily affecting the Aicardi syndrome market because of the technology advancement in healthcare. These technologies allow for long distance consultations, continuous patient monitoring and increased access to specialized healthcare thereby eliminating geographical boundaries. This trend has gained relevance especially in the era of COVID-19, where virtual healthcare has become a fundamental means by which sufferers of Aicardi syndrome and their families retain ongoing support.
Research and development activities have picked up pace in the Aicardi syndrome markets with an aim to understand genetic mechanisms that underlie this disorder as well as look for possible treatment options. The partnerships between academic institutions, pharmaceutical companies and research institutes seek to demystify the mystery surrounding Aicardi’s syndrome hence coming up with therapies that can be used on a focused group. This could lead to drugs whose administration would address specific challenges posed by this rare genetic disorder thus necessitating further studies.
Equally important for Aicardi Syndrome is regulatory considerations; therefore, regulatory agencies play indispensable roles in supporting and expediting potential treatments through their vetting process before they come into market. Regulatory agencies need partnership from medical practitioners if they want to navigate safely through all regulations so that they can develop safe treatment strategies for those individuals with Aicardi syndrome.
Aicardi Syndrome Market Highlights:
Aicardi Syndrome Market Scenario
Aicardi Syndrome market is expected to grow USD 3.4 Billion at a CAGR 5.80% steady pace over the forecast period of 2023–2030. Aicardi syndrome is a rare genetic malformation syndrome characterized by the partial or complete absence of a key structure in the brain called the corpus callosum. The disorder primarily affects females, the mutation specifically occurs on the X chromosome. Symptoms of Aicardi syndrome include rib and spine abnormalities, such as scoliosis. Children with the syndrome may also have unusual facial features, such as larger ears, a flatter nose, or a smaller space between the upper lip and nose. Additionally, Aicardi syndrome can result in poorly developed eyes, impaired vision or blindness. The increasing research activities on rare disorders contribute to the growth of the market. For instance, Aicardi Syndrome Foundation, a non-profit organization contributes to ongoing research of Aicardi syndrome at Baylor University, Texas Children’s Hospital and The University of California, San Francisco.
The rising incidence of Aicardi syndrome, growing prevalence of rare disorders, technological advancements in the medical sector, and growing research and development (R&D) activities, are anticipated to drive the growth of the market during the forecast period. Despite the driver, the lack of awareness about the syndrome in the developing regions and difficulties in diagnosis may restrain the growth of the Aicardi syndrome market over the forecast period.
Segmentation
The Aicardi syndrome market has been segmented into diagnosis, treatment, and end-user.
The market, based on diagnosis, has been segmented into magnetic resonance imaging (MRI), eye examination, and others.
The market, by treatment, has been segmented into seizure medication, surgery, physical therapy, occupational therapy, speech therapy, vision therapy, and others. The market, by seizure medication, is further segmented into vigabatrin, sodium valproate, and others.
The market, by end-user, has been segmented into hospital and clinics, diagnostic centers, and others.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Aicardi syndrome market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European Aicardi syndrome market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.Â
The Aicardi syndrome market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Aicardi Syndrome market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key players
Siemens Healthineers, General Electric Company, Koninklijke Philips N.V., Hitachi, Ltd., Canon Medical Systems Europe B.V., Medtronic, Smart Speech Therapy, Therapy Solutions Inc., Carestream Health, Esaote SpA, Lundbeck, and Novartis AG are some of the key players in the Aicardi syndrome market.
Regional Market Summary
Aicardi Syndrome Market Share (%), by Region, 2017
Source: World Health Organization (WHO), Office for National Statistics, National Organization for Rare Disorders
Geographically, the Americas is anticipated to dominate the Aicardi Syndrome market owing to a rising research and development funding for rare diseases, and presence of well-developed healthcare infrastructure. Additionally, increasing healthcare expenditure provides a favorable background for pharmaceutical companies which is thereby expected to contribute to the market growth in the region. According to the Centers for Disease Control and Prevention (CDC), total national health expenditures were USD 3.2 trillion in 2015.
Europe is expected to hold the second largest position in the Aicardi syndrome market. The market growth in this region is attributed to the growing awareness of rare diseases and increasing research and development (R&D) activities. According to the Office for National Statistics, gross domestic expenditure on research and development (R&D) was Euro 33.1 billion (USD 35.2 billion) in 2016.
Asia-Pacific is anticipated to be the fastest growing market owing to the growing development in healthcare infrastructure, increasing number of regional expansions by multinational biopharmaceutical companies, and increasing government expenditure for the healthcare sector.
The Middle East & Africa is anticipated to account for the lowest market share in the Aicardi syndrome market due to low development, lack of technical knowledge, and poor medical facilities in developing economies in this region.
Market of Aicardi Syndrome, by Diagnosis
- Magnetic Resonance Imaging (MRI)
- Eye Examination
- Others
Market of Aicardi Syndrome, by Treatment
- Seizure Medication
- Vigabatrin
- Sodium Valproate
- Others
- Surgery
- Physical Therapy
- Occupational Therapy
- Speech Therapy
- Vision therapy
- Others
Market of Aicardi Syndrome, by End-User
- Hospital Clinics
- Diagnostic Centers
- Others
Market of Aicardi Syndrome, by Region
-
Americas- North America
- US
- Canada
- South America
-
Europe- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
-
Asia-Pacific- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
-
The Middle East & Africa- Middle East
- Africa
Intended Audience
- Pharmaceutical Companies
- Research and Development (R&D) Companies
- Diagnostic Laboratories
- Government Research Institute
- Academic Institutes and Universities
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
